Ligosan (Doxycycline Hyclate)

Doxycycline hyclate works by binding to the 30S subunit of bacterial ribosomes, preventing the attachment of aminoacyl‑tRNA to the mRNA‑ribosome complex. This blocks protein synthesis, halting bacterial growth and replication. The resulting bacteriostatic effect limits the spread of infection in the periodontal tissues and other sites where the drug is active.

The specific dose of Ligosan is determined by the prescribing clinician based on the patient’s condition, severity of disease, renal function, and other individual factors. Healthcare professionals follow local prescribing guidelines and adjust the regimen as needed; patients should not alter the dose without medical advice.

Ligosan is classified as pregnancy category D, indicating evidence of risk to the fetus. It should be used during pregnancy only when the potential benefit justifies the risk. Doxycycline is excreted in breast milk, so nursing mothers should discuss potential infant exposure with their healthcare provider before continuing therapy.

To order Ligosan, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, and will request verification of trade or institutional credentials. After confirmation, the sales team provides pricing, availability, shipping details (including any cold‑chain requirements), and assists with import documentation.

Ligosan (doxycycline hyclate) offers a broad spectrum of activity similar to other tetracyclines such as minocycline, but it has a longer half‑life, allowing once‑daily dosing in many regimens. Doxycycline generally has lower rates of vestibular side effects compared with minocycline and is less likely to cause severe pigmentation changes. Choice of agent depends on the infection type, patient tolerance, and local resistance patterns.

Ligosan tablets should be stored at ambient temperature, below 25 °C, in the original packaging to protect them from moisture and direct sunlight. Keep the product out of reach of children and avoid storing in bathrooms or other humid environments. No refrigeration is required for this oral formulation.

Ligosan is supplied as oral tablets intended for periodontal use. The tablets are taken by mouth with a full glass of water, preferably on an empty stomach to enhance absorption, unless the prescriber advises otherwise. Patients should remain upright for at least 30 minutes after dosing to reduce the risk of esophageal irritation.

Serious adverse reactions to Ligosan include severe allergic responses such as anaphylaxis, Stevens‑Johnson syndrome, hepatotoxicity, intracranial hypertension, and Clostridioides difficile‑associated colitis. Patients should seek immediate medical attention if they develop rash, blistering, persistent vomiting, severe abdominal pain, visual changes, or signs of liver dysfunction while on therapy.

Ligosan is contraindicated in individuals with a known hypersensitivity to doxycycline, other tetracyclines, or any component of the formulation. It should also be avoided in patients with severe renal impairment unless dose‑adjusted, and in those with a history of intracranial hypertension or severe liver disease. Pregnant women should only use it when the potential benefit outweighs the risk.